IP Library Granted Patent US 12,304,889
Granted Patent B2
US 12,304,889 · App. 17/603,536 · Granted May 20, 2025

Method for producing cis-(-)-flocino piperidol

Inventors: Hiroto Tatamidani (Osaka, JP); Shinjiro Tsuyumine (Osaka, JP); Yoko Takahashi (Osaka, JP)
Assignee: Sumitomo Pharma Co., LTD.
C07D211/42C07B57/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,304,889
App. No.
17/603,536
Granted
May 20, 2025
Kind
B2
Abstract

The present invention provides a method in which when using (+)-dibenzoyl-D-tartaric acid to optically divide (±)-1-methyl-4-(2,4,6-trimethoxyphenyl)-3-piperidinone, an ether-based solvent is added and an extremely high yield of (R)-1-methyl-4-(2,4,6-trimethoxyphenyl)-3-piperidinone (+)-dibenzoyl-D-tartrate is thereby obtained, a slurry thereof is treated with a base, a “three-dimensionally bulky reducing agent” is subsequently used, and cis-(−)-flocinopiperidol is thereby produced with surprisingly high selectivity.

Claims (32)

1. A manufacturing method of cis-(−)-flocinopiperidol represented by formula (I):

or a salt thereof or a solvate thereof, comprising the following steps:

(b) forming (R)-1-methyl-4-(2,4,6-trimethoxyphenyl)-3-piperidinone (+)-dibenzoyl-D-tartrate represented by formula (5):

or a solvate thereof by:

(i) reacting (+)-1-methyl-4-(2,4,6-trimethoxyphenyl)-3-piperidinone represented by formula (3):

or a salt thereof or a solvate thereof with (+)-dibenzoyl-D-tartrate represented by formula (4):

or a salt thereof or a solvate thereof in a reaction solvent;

(ii) precipitating (R)-1-methyl-4-(2,4,6-trimethoxyphenyl)-3-piperidinone (+)-dibenzoyl-D-tartrate represented by formula (5) by adding a poor solvent to a reaction solution of step (i), wherein the poor solvent is an ether-based solvent selected from diisopropyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 2-methyltetrahydrofuran and cyclopentyl methyl ether;

(c) reacting (R)-1-methyl-4-(2,4,6-trimethoxyphenyl)-3-piperidinone (+)-dibenzoyl-D-tartrate represented by formula (5):

or a solvate thereof with an organic base in a solvent to manufacture (R)-1-methyl-4-(2,4,6-trimethoxyphenyl)-3-piperidinone represented by formula (6):

or a salt thereof or a solvate thereof, wherein the organic base is a tertiary amine; and

(d) reacting (R)-1-methyl-4-(2,4,6-trimethoxyphenyl)-3-piperidinone represented by formula (6):

or a salt thereof or a solvate thereof with a compound of formula (7):

or a solvate thereof, in a solvent, to manufacture cis-(−)-flocinopiperidol represented by formula (I):

or a salt thereof or a solvate thereof, wherein M in formula (7) is lithium, sodium, or potassium.

2. The manufacturing method of claim 1 , wherein M in formula (7) used in step (d) is lithium.

3. The manufacturing method of claim 1 , wherein a compound of formula (I) or a solvate thereof is obtained in step (d) by extracting a product after a reduction reaction with an acidic aqueous solution and increasing the pH of the extraction solution.

4. The manufacturing method of claim 1 , wherein a compound of formula (I) or a solvate thereof is obtained in step (d) by extracting a product after a reduction reaction with an acidic aqueous solution and dripping the extraction solution into a basic aqueous solution.

5. The manufacturing method of claim 3 , wherein the pH of the acidic aqueous solution is 6.0 to 6.5 in step (d).

6. The manufacturing method of claim 3 , wherein the pH of the acidic aqueous solution is 6.0 in step (d).

7. The manufacturing method of claim 1 , wherein the solvent used in step (c) is an ether-based solvent.

8. The manufacturing method of claim 1 , wherein step (d) is performed using a base-neutralized product in a state of a solution without isolation in step (c).

9. The manufacturing method of claim 1 , wherein the reaction solvent in step (b) is at least one reaction solvent selected from an ester-based solvent, an ether-based solvent, an alcohol-based solvent, an amide-based solvent, a nitrile-based solvent, and an aromatic solvent.

10. The manufacturing method of claim 1 , wherein the reaction solvent used in step (b) is an alcohol-based solvent.

11. The manufacturing method of claim 1 , further comprising the following step (a) before step (b):

(a) reacting (+)-1-methyl-4-(2,4,6-trimethoxyphenyl) piperidine-3-ol represented by formula (1):

or a salt thereof or a solvate thereof with a compound represented by formula (2):

or a salt thereof or a solvate thereof and dialkyl sulfoxide to manufacture (+)-1-methyl-4-(2,4,6-trimethoxyphenyl)-3-piperidinone represented by formula (3):

or a salt thereof or a solvate thereof.

12. The manufacturing method of claim 11 , wherein Y in formula (2) used in step (a) is pyridine.

13. The manufacturing method of claim 11 , wherein the reaction in step (a) is performed at a temperature of −10° C. or higher.

14. The manufacturing method of claim 11 , wherein the reaction in step (a) is performed at a temperature from 0° C. to 30° C.

Assignments (3)
CHANGE OF NAME Recorded May 20, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 059972/0983 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICANT ADDRESS PREVIOUSLY RECORDED ON REEL 057796 FRAME 0596. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 20, 2021
From: TATAMIDANI, HIROTO; TSUYUMINE, SHINJIRO; TAKAHASHI, YOKI
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 057879/0970 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2021
From: TATAMIDANI, HIROTO; TSUYUMINE, SHINJIRO; TAKAHASHI, YOKO
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 057796/0596 →
Priority Claims (1)
JP 2019-079299 · Apr 18, 2019 · national
Continuity (1)
Related Publication 20220220072A1 · Jul 14, 2022
References Cited (14)
US 4900727A · Kattige · 1990 [cited by examiner]
US 5849733A · Kim · 1998 [cited by examiner]
US 5908934A · Kim · 1999 [cited by examiner]
WO 9813344A1 · 1998 [cited by applicant]
Chikashita “Stereoselective syn-reduction of (R)-4-acyl-2,2-dimethyl-1,3-dioxolanes with metal hydride reagents.” Bulletin of the Chemical Society of Japan, 1989, 62(6), 2121-3. [cited by examiner]
Hubbard “Lithium Tri-sec-butylborohydride1” Encyclopedia of Reagents for Organic Synthesis 2012, pp. 1-6. [cited by examiner]
Kozma “CRC Handbook of Optical Resolutions Via Diastereomeric Salt Formation” 2002 CRC Press: Washington, DC, Chapters 6. [cited by examiner]
Caron, “Large-Scale Oxidations in the Pharmaceutical Industry” Chemical Reviews 2006, 106(7), 2943-2989. [cited by examiner]
Arai “Carbonyl Hydroboration” Chapter 7 in Modern Reduction Methods. Edited by Pher G. Andersson and Ian J. Munslow. 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. [cited by examiner]
Kim et al., “Thio- and Oxoflavopiridols, Cyclin-Dependent Kinase 1-Selective Inhibitors: Synthesis and Biological Effects,” [cited by applicant]
Naik et al., “An Antiinflammatory Cum Immunomodulatory Piperidinylbenzopyranone From Dysoxylum Binectariferum: Isolation, Structure and Total Synthesis,” [cited by applicant]
The Chemical Society of Japan, “The fifth series of experimental chemistry 14, Synthesis of Organic Compounds II—alcohol and amine”, (with English translation), Maruzen Inc., 2005 (26 pages). [cited by applicant]
The Chemical Society of Japan, “The fourth series of experimental chemistry 26, Organic Synthesis VIII—asymmetric synthesis, reduction, sugar, and labeled compound”, (with English translation), Maruzen Inc., 1992 (4 pag… [cited by applicant]
The Chemical Society of Japan, “The fifth series of experimental chemistry 17, Synthesis of Organic Compounds V—oxidation reaction,” (with English translation), Maruzen Inc., 2004 (92 pages). [cited by applicant]